NeoCore Technology Co., Ltd. (TPEX:4131)
30.00
-0.10 (-0.33%)
Nov 20, 2026, 11:29 AM CST
NeoCore Technology Revenue
NeoCore Technology had revenue of 49.27M TWD in the quarter ending September 30, 2026, a decrease of -10.74%. This brings the company's total for the last twelve months to 271.62M, up 42.88% year-over-year. In the year 2025, NeoCore Technology had annual revenue of 244.66M with 297.52% growth. That makes NeoCore Technology the 38,229th largest company in the world by revenue and 1,992nd in Taiwan.
Revenue (ttm)
271.62M
Revenue Growth
+42.88%
P/S Ratio
4.40
Revenue / Employee
6.17M
Employees
44
Market Cap
1.20B
Revenue by Segment
- Contact Lens Division 212.70M 86.9%
- Biotechnology 31.96M 13.1%
Fiscal year ended Dec 31, 2025 See the full NeoCore Technology breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 244.66M | 183.11M | 297.52% |
| Dec 31, 2024 | 61.55M | -3.18M | -4.92% |
| Dec 31, 2023 | 64.73M | -24.24M | -27.24% |
| Dec 31, 2022 | 88.97M | 42.00K | 0.05% |
| Dec 31, 2021 | 88.93M | -4.42M | -4.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.03B |
| GenMont Biotech Incorporation | 396.64M |
| Abnova (Taiwan) | 337.63M |
| TaiRx | 29.44M |
| Anti-Microbial Savior BioteQ | 1.26M |